Appraisals of Sero-detection of Treponema pallidum Antibodies IgG and IgM and CBC parameters among Spontaneous Recurrent Miscarriage in Women- Case-Control Study in Gezira State 2018
Sero-detection of Treponema pallidum Antibodies IgG and IgM and CBC parameters among Spontaneous Recurrent Miscarriage Women.
DOI:
https://doi.org/10.22317/imj.v6i1.1085Keywords:
Treponema pallidum, antibodies, recurrent miscarriage women, ELIZA.Abstract
Objectives: We determined Sero-detection of Treponema pallidum (IgG and IgM antibodies) using ELIZA techniques women with recurrent Miscarriage in Gezira state and appraisal of other risk factors.
Methods: in this case-control, a hospital-based study conducted at Wad Madani teaching hospital Department of Obstetrics gynecological, Gezira State, Sudan. Ninety subjects were involved, 45 were women with recurrent Miscarriage, and controls were healthy pregnant women (no miscarriage). Serum Treponema pallidum antibodies were estimated by the ELIZA method.
Results: Sero-detection of IgG and IgM antibodies by using ELIZA techniques, a total of 45 miscarriage women (cases) for IgM 6 (13.3%) were positive, and 39 (48.8%) were negative for Treponema pallidum by using ELISA techniques. A total of 45 non-miscarriage women (control) for IgM 4 (8.9%) were positive, and 41(91.1%) were negative For Treponema pallidum by using ELISA techniques. A total of 45 miscarriage women (cases) for IgG 13(28.9%) were positive, 32(71.1%) were negative. Furthermore, IgG for non-miscarriage, like IgM 4(8.9%), was positive, and 41(91.1%) were negative.
Conclusion: Higher prevalence of Treponema pallidum IgG seropositivity among pregnant women who reported miscarriages compared to those who did not report miscarriages (p < 0.001) while no association between IgM seropositivity and pregnant women who reported miscarriages.
References
2. WHO Office of HIV/AIDS and STDs. An overview of selected curable STDs. Syphilis estimates, 1995. Geneva, Switzerland: World Health Organization; 1995.
3. Ameeta ES, Romanowski B. Syphilis: a review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12:187–209.
4. Robert B, Stroube MD. Infectious syphilis: the return of an epidemic Medscape Infect Dis. (serial online) Medscape; 2008
5. Fonck K, Claeys P, Bashir F, Bwayo J, Fransen L, Temmerman M. Syphilis control during pregnancy; effectiveness and sustainability of the decentralized program. Am J Public Health. 2001;91:705-707.
6. Kustner HG, Swanevelder JP, Van MK. The South Africa HIV epidemic, reflected by nine provincial epidemics, 19901996, South Africa Med J. 1998;88(1):1235-1320.
7. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility.6th ed. Philadelphia: Lippincott Williams & Wilkins; 1999.
8. Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril 1996; 65: 503-9.
9. Saab F. Syphilis prevalence in pregnant women who miscarried served by the maternity protection program - PPG Sergipe State, 2005 to 2007. 2016
10. World Health Organization. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission (EMTCT) of HIV and syphilis, Geneva.2014.
11. Abreu LG, Santana LF, Navarro PAAS, Reis RM, Ferriani RA, et al.The pregnancy rate in women undergoing assisted reproductive techniques is less from 30 years. Rev Bras Gynecol Obstet 2006;28: 32-37.
12. Magalhães DMS, Kawaguchi IAL, Dias A, Calderon IMP. Maternal and congenital syphilis: still a challenge. Cad Public Health 2013;29: 1109-1120.